SCHEMBL4757157

SCHEMBL4757157

Cc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.49
FFAR2 O15552 1/20 0.45
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 1/20 0.43
AVPR2 P30518 1/20 0.43
GPR27 Q9NS67 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
POLQ O75417 1/20 0.43
PKM P14618 1/20 0.43
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757105 0.89 FFAR2 (0.44) STAT3FFAR2KMT2AMAPTMEN1
SCHEMBL4755924 0.89 STAT3 (0.63) STAT3FFAR2KMT2AMEN1LMNA
SCHEMBL4757189 0.88 FFAR2 (0.48) STAT3FFAR2KMT2AKDM4EMAPT
SCHEMBL4755857 0.88 STAT3 (0.47) STAT3FFAR2KMT2AKDM4EMAPT
SCHEMBL4755898 0.86 STAT3 (0.63) STAT3FFAR2KMT2AMEN1RAB9A
SCHEMBL4757155 0.84 NPC1 (0.59) FFAR2KMT2AKDM4EMAPTMEN1
SCHEMBL10114537 0.84 RAB9A (0.41) STAT3FFAR2KMT2AKDM4EMAPT
SCHEMBL24073698 0.81 STAT3 (0.52) STAT3KMT2AKDM4EMAPTMEN1
SCHEMBL4756952 0.80 RAB9A (0.57) KMT2AKDM4EMAPTMEN1LMNA
SCHEMBL4756933 0.80 RAB9A (0.53) STAT3FFAR2KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885FFAR2 4045/4885KMT2A 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.